CHORUS AVIATION INC (CHR.CA) Fundamental Analysis & Valuation

TSX:CHRCA17040T8885

Current stock price

23.08 CAD
+0.59 (+2.62%)
Last:

This CHR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CHR.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CHR was profitable.
  • In the past year CHR had a positive cash flow from operations.
  • In multiple years CHR reported negative net income over the last 5 years.
  • In the past 5 years CHR always reported a positive cash flow from operatings.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

  • CHR's Return On Assets of 6.01% is amongst the best of the industry. CHR outperforms 83.33% of its industry peers.
  • With an excellent Return On Equity value of 15.50%, CHR belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
  • CHR has a better Return On Invested Capital (7.56%) than 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 5.94%.
  • The last Return On Invested Capital (7.56%) for CHR is above the 3 year average (6.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.01%
ROE 15.5%
ROIC 7.56%
ROA(3y)-2.94%
ROA(5y)-1.76%
ROE(3y)-10.29%
ROE(5y)-6.33%
ROIC(3y)6.55%
ROIC(5y)5.67%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

1.3 Margins

  • CHR has a better Profit Margin (5.98%) than 83.33% of its industry peers.
  • CHR's Profit Margin has improved in the last couple of years.
  • CHR's Operating Margin of 7.57% is amongst the best of the industry. CHR outperforms 83.33% of its industry peers.
  • In the last couple of years the Operating Margin of CHR has declined.
  • CHR has a Gross Margin of 67.08%. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of CHR has declined.
Industry RankSector Rank
OM 7.57%
PM (TTM) 5.98%
GM 67.08%
OM growth 3Y-16.68%
OM growth 5Y-17.04%
PM growth 3Y54.29%
PM growth 5Y6.46%
GM growth 3Y-2.08%
GM growth 5Y-3.91%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

5

2. CHR.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHR is destroying value.
  • Compared to 1 year ago, CHR has less shares outstanding
  • The number of shares outstanding for CHR has been increased compared to 5 years ago.
  • CHR has a better debt/assets ratio than last year.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CHR has an Altman-Z score of 0.94. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
  • CHR has a Altman-Z score of 0.94. This is comparable to the rest of the industry: CHR outperforms 50.00% of its industry peers.
  • CHR has a debt to FCF ratio of 13.43. This is a negative value and a sign of low solvency as CHR would need 13.43 years to pay back of all of its debts.
  • CHR has a better Debt to FCF ratio (13.43) than 83.33% of its industry peers.
  • CHR has a Debt/Equity ratio of 0.61. This is a neutral value indicating CHR is somewhat dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.61, CHR belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 13.43
Altman-Z 0.94
ROIC/WACC0.9
WACC8.36%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.30 indicates that CHR should not have too much problems paying its short term obligations.
  • CHR's Current ratio of 1.30 is fine compared to the rest of the industry. CHR outperforms 66.67% of its industry peers.
  • A Quick Ratio of 0.69 indicates that CHR may have some problems paying its short term obligations.
  • The Quick ratio of CHR (0.69) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.69
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2

3. CHR.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 58.94% over the past year.
  • Measured over the past years, CHR shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.51% on average per year.
  • CHR shows a decrease in Revenue. In the last year, the revenue decreased by -6.30%.
  • CHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.77% yearly.
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-6.21%
Revenue growth 5Y6.77%
Sales Q2Q%-9.33%

3.2 Future

  • Based on estimates for the next years, CHR will show a decrease in Earnings Per Share. The EPS will decrease by -8.54% on average per year.
  • The Revenue is expected to decrease by -0.24% on average over the next years.
EPS Next Y-18.54%
EPS Next 2Y-4.34%
EPS Next 3Y-7.18%
EPS Next 5Y-8.54%
Revenue Next Year-4%
Revenue Next 2Y-1.42%
Revenue Next 3Y-0.35%
Revenue Next 5Y-0.24%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

6

4. CHR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.62, which indicates a very decent valuation of CHR.
  • 100.00% of the companies in the same industry are more expensive than CHR, based on the Price/Earnings ratio.
  • CHR is valuated cheaply when we compare the Price/Earnings ratio to 26.21, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 11.81, the valuation of CHR can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, CHR is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of CHR to the average of the S&P500 Index (23.13), we can say CHR is valued slightly cheaper.
Industry RankSector Rank
PE 9.62
Fwd PE 11.81
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CHR is valued a bit cheaper than 66.67% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR indicates a somewhat cheap valuation: CHR is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.38
EV/EBITDA 4.28
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The excellent profitability rating of CHR may justify a higher PE ratio.
  • CHR's earnings are expected to decrease with -7.18% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.34%
EPS Next 3Y-7.18%

5

5. CHR.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.62%, CHR has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.99, CHR pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, CHR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

  • The dividend of CHR is nicely growing with an annual growth rate of 6.02%!
  • CHR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.02%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 2026 1 2 3

5.3 Sustainability

  • CHR pays out 4.99% of its income as dividend. This is a sustainable payout ratio.
DP4.99%
EPS Next 2Y-4.34%
EPS Next 3Y-7.18%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M
CHR.CA Dividend Payout.CHR.CA Dividend Payout, showing the Payout Ratio.CHR.CA Dividend Payout.PayoutRetained Earnings

CHR.CA Fundamentals: All Metrics, Ratios and Statistics

CHORUS AVIATION INC

TSX:CHR (4/6/2026, 7:00:00 PM)

23.08

+0.59 (+2.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners4.93%
Inst Owner ChangeN/A
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap539.84M
Revenue(TTM)1.32B
Net Income(TTM)78.74M
Analysts80
Price Target31.18 (35.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly Dividend0.16
Dividend Growth(5Y)6.02%
DP4.99%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.44%
Min EPS beat(2)-12.73%
Max EPS beat(2)3.86%
EPS beat(4)3
Avg EPS beat(4)1.51%
Min EPS beat(4)-12.73%
Max EPS beat(4)11.03%
EPS beat(8)6
Avg EPS beat(8)21.63%
EPS beat(12)6
Avg EPS beat(12)4.92%
EPS beat(16)7
Avg EPS beat(16)0.38%
Revenue beat(2)0
Avg Revenue beat(2)-5.74%
Min Revenue beat(2)-7.4%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.93%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.95%
Revenue beat(8)1
Avg Revenue beat(8)-4.99%
Revenue beat(12)4
Avg Revenue beat(12)-2.69%
Revenue beat(16)6
Avg Revenue beat(16)-1.25%
PT rev (1m)0%
PT rev (3m)3.05%
EPS NQ rev (1m)0.48%
EPS NQ rev (3m)2.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.8%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 9.62
Fwd PE 11.81
P/S 0.41
P/FCF 19.38
P/OCF 8.6
P/B 1.06
P/tB 1.09
EV/EBITDA 4.28
EPS(TTM)2.4
EY10.4%
EPS(NY)1.96
Fwd EY8.47%
FCF(TTM)1.19
FCFY5.16%
OCF(TTM)2.68
OCFY11.62%
SpS56.28
BVpS21.71
TBVpS21.2
PEG (NY)N/A
PEG (5Y)N/A
Graham Number34.24
Profitability
Industry RankSector Rank
ROA 6.01%
ROE 15.5%
ROCE 9.47%
ROIC 7.56%
ROICexc 7.77%
ROICexgc 7.87%
OM 7.57%
PM (TTM) 5.98%
GM 67.08%
FCFM 2.12%
ROA(3y)-2.94%
ROA(5y)-1.76%
ROE(3y)-10.29%
ROE(5y)-6.33%
ROIC(3y)6.55%
ROIC(5y)5.67%
ROICexc(3y)7.32%
ROICexc(5y)6.2%
ROICexgc(3y)7.4%
ROICexgc(5y)6.25%
ROCE(3y)8.21%
ROCE(5y)7.1%
ROICexgc growth 3Y14.68%
ROICexgc growth 5Y8.46%
ROICexc growth 3Y14.56%
ROICexc growth 5Y8.27%
OM growth 3Y-16.68%
OM growth 5Y-17.04%
PM growth 3Y54.29%
PM growth 5Y6.46%
GM growth 3Y-2.08%
GM growth 5Y-3.91%
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 13.43
Debt/EBITDA 1.49
Cap/Depr 32.52%
Cap/Sales 2.65%
Interest Coverage 5.51
Cash Conversion 30.33%
Profit Quality 35.38%
Current Ratio 1.3
Quick Ratio 0.69
Altman-Z 0.94
F-Score7
WACC8.36%
ROIC/WACC0.9
Cap/Depr(3y)32.03%
Cap/Depr(5y)32.8%
Cap/Sales(3y)3.17%
Cap/Sales(5y)4.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.94%
EPS 3Y-9.92%
EPS 5Y-3.51%
EPS Q2Q%-5%
EPS Next Y-18.54%
EPS Next 2Y-4.34%
EPS Next 3Y-7.18%
EPS Next 5Y-8.54%
Revenue 1Y (TTM)-6.3%
Revenue growth 3Y-6.21%
Revenue growth 5Y6.77%
Sales Q2Q%-9.33%
Revenue Next Year-4%
Revenue Next 2Y-1.42%
Revenue Next 3Y-0.35%
Revenue Next 5Y-0.24%
EBIT growth 1Y4.51%
EBIT growth 3Y-21.86%
EBIT growth 5Y-11.43%
EBIT Next Year72.5%
EBIT Next 3Y17.02%
EBIT Next 5Y10.81%
FCF growth 1Y-86.87%
FCF growth 3Y-49.57%
FCF growth 5YN/A
OCF growth 1Y-76.32%
OCF growth 3Y-39.22%
OCF growth 5Y-16.72%

CHORUS AVIATION INC / CHR.CA Fundamental Analysis FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 5 / 10 to CHR.CA.


Can you provide the valuation status for CHORUS AVIATION INC?

ChartMill assigns a valuation rating of 6 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Fairly Valued.


What is the profitability of CHR stock?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 8 / 10.


What is the expected EPS growth for CHORUS AVIATION INC (CHR.CA) stock?

The Earnings per Share (EPS) of CHORUS AVIATION INC (CHR.CA) is expected to decline by -18.54% in the next year.


Can you provide the dividend sustainability for CHR stock?

The dividend rating of CHORUS AVIATION INC (CHR.CA) is 5 / 10 and the dividend payout ratio is 4.99%.